Literature DB >> 21290408

Regulation of cytokine expression by Schwann cells in response to α2-macroglobulin binding to LRP1.

Yang Shi1, Tomonori Yamauchi, Alban Gaultier, Shinako Takimoto, W Marie Campana, Steven L Gonias.   

Abstract

Binding of activated α(2)-macroglobulin (α(2)M) to LDL receptor-related protein-1 (LRP1) in Schwann cells activates ERK/MAP kinase and Akt and thereby promotes cell survival and migration. The goal of this study was to determine whether α(2)M binding to LRP1 regulates expression of cytokines and chemokines. To assess the LRP1 response selectively, we studied primary cultures of rat Schwann cells. In a screening assay that detects 84 gene products, monocyte chemoattractant protein-1 (MCP-1/CCL2) mRNA expression was increased more than 13-fold in Schwann cells treated with activated α(2)M. The effects of α(2)M on MCP-1 expression were selective, because expression of the general proinflammatory cytokine tumor necrosis factor-α (TNF-α) was not induced. We confirmed that α(2)M selectively induces expression of MCP-1 and not TNF-α in single-target qPCR assays. MCP-1 protein accumulated at increased levels in conditioned medium of α(2)M-treated cells. LRP1 was necessary for induction of MCP-1 expression, as determined in experiments with the LRP1 antagonist receptor-associated protein, a mutated form of full-length α(2)M that does not bind LRP1, and in studies with Schwann cells in which LRP1 was silenced. Inhibiting ERK/MAP kinase activation blocked expression of MCP-1. These studies support a model in which LRP1 regulates multiple aspects of Schwann cell physiology in the response to PNS injury.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21290408      PMCID: PMC3560970          DOI: 10.1002/jnr.22576

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  39 in total

Review 1.  Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation.

Authors:  L Sottrup-Jensen
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

2.  Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes.

Authors:  T Chase; E Shaw
Journal:  Biochemistry       Date:  1969-05       Impact factor: 3.162

3.  Fibronectin and polylysine requirement for proliferation of neuroblastoma cells in defined medium.

Authors:  J E Bottenstein; G H Sato
Journal:  Exp Cell Res       Date:  1980-10       Impact factor: 3.905

4.  The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule.

Authors:  A J Barrett; M A Brown; C A Sayers
Journal:  Biochem J       Date:  1979-08-01       Impact factor: 3.857

5.  Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin.

Authors:  M J Imber; S V Pizzo
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

6.  Conformation and protease binding activity of binary and ternary human alpha 2-macroglobulin-protease complexes.

Authors:  S L Gonias; S V Pizzo
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

7.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

8.  Physical properties of human alpha 2-macroglobulin following reaction with methylamine and trypsin.

Authors:  S L Gonias; J A Reynolds; S V Pizzo
Journal:  Biochim Biophys Acta       Date:  1982-08-10

9.  Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration.

Authors:  A Wayne Orr; Carrie A Elzie; Dennis F Kucik; Joanne E Murphy-Ullrich
Journal:  J Cell Sci       Date:  2003-07-15       Impact factor: 5.285

10.  Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons.

Authors:  Zhihua Qiu; Bradley T Hyman; G William Rebeck
Journal:  J Biol Chem       Date:  2004-05-28       Impact factor: 5.157

View more
  6 in total

Review 1.  LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system.

Authors:  Steven L Gonias; W Marie Campana
Journal:  Am J Pathol       Date:  2013-10-12       Impact factor: 4.307

2.  The unfolded protein response is a major mechanism by which LRP1 regulates Schwann cell survival after injury.

Authors:  Elisabetta Mantuano; Kenneth Henry; Tomonori Yamauchi; Nobuhiko Hiramatsu; Kazuyo Yamauchi; Sumihisa Orita; Kazuhisa Takahashi; Jonathan H Lin; Steven L Gonias; W Marie Campana
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

3.  Evidence that LDL receptor-related protein 1 acts as an early injury detection receptor and activates c-Jun in Schwann cells.

Authors:  Andreas Flütsch; Kenneth Henry; Elisabetta Mantuano; Michael S Lam; Masataka Shibayama; Kazuhisa Takahashi; Steven L Gonias; Wendy M Campana
Journal:  Neuroreport       Date:  2016-12-14       Impact factor: 1.837

Review 4.  Unwrapping the unappreciated: recent progress in Remak Schwann cell biology.

Authors:  Breanne L Harty; Kelly R Monk
Journal:  Curr Opin Neurobiol       Date:  2017-11-06       Impact factor: 6.627

5.  Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages.

Authors:  Tatiana Smirnova; Laura Bonapace; Gwen MacDonald; Shunya Kondo; Jeffrey Wyckoff; Hilmar Ebersbach; Bérengère Fayard; Arno Doelemeyer; Marie-May Coissieux; Marinus R Heideman; Mohamed Bentires-Alj; Nancy E Hynes
Journal:  Oncotarget       Date:  2016-12-13

6.  Nanoparticles carrying neurotrophin-3-modified Schwann cells promote repair of sciatic nerve defects.

Authors:  Haibin Zong; Hongxing Zhao; Yilei Zhao; Jingling Jia; Libin Yang; Chao Ma; Yang Zhang; Yuzhen Dong
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.